Kirtland Hills Capital Management LLC Acquires 497 Shares of Zoetis Inc. (NYSE:ZTS)

Kirtland Hills Capital Management LLC grew its position in shares of Zoetis Inc. (NYSE:ZTS) by 6.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,590 shares of the company’s stock after acquiring an additional 497 shares during the quarter. Zoetis comprises 0.8% of Kirtland Hills Capital Management LLC’s holdings, making the stock its 28th largest holding. Kirtland Hills Capital Management LLC’s holdings in Zoetis were worth $1,678,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ZTS. Intech Investment Management LLC lifted its stake in Zoetis by 94.6% in the first quarter. Intech Investment Management LLC now owns 2,320 shares of the company’s stock worth $393,000 after purchasing an additional 1,128 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Zoetis by 49.6% in the first quarter. Acadian Asset Management LLC now owns 25,051 shares of the company’s stock valued at $4,235,000 after purchasing an additional 8,302 shares during the period. MQS Management LLC purchased a new stake in shares of Zoetis during the first quarter valued at about $443,000. Crewe Advisors LLC acquired a new position in shares of Zoetis during the first quarter valued at about $154,000. Finally, CreativeOne Wealth LLC increased its holdings in Zoetis by 16.7% in the 1st quarter. CreativeOne Wealth LLC now owns 13,323 shares of the company’s stock worth $2,254,000 after buying an additional 1,904 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on ZTS. Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Stifel Nicolaus boosted their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. JPMorgan Chase & Co. upped their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. BTIG Research raised their target price on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Finally, Argus raised shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Ten research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $221.44.

Zoetis Trading Down 0.5 %

Shares of NYSE:ZTS opened at $175.57 on Wednesday. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The stock has a market cap of $79.21 billion, a PE ratio of 33.00, a P/E/G ratio of 2.71 and a beta of 0.90. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The business has a 50 day moving average of $186.47 and a 200-day moving average of $180.51.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the business earned $1.36 EPS. As a group, equities research analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be issued a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s payout ratio is 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.